Edition:
United States

AxoGen Inc (AXGN.OQ)

AXGN.OQ on NASDAQ Stock Exchange Capital Market

35.90USD
4:00pm EDT
Change (% chg)

$0.40 (+1.13%)
Prev Close
$35.50
Open
$35.35
Day's High
$36.50
Day's Low
$35.25
Volume
94,676
Avg. Vol
106,941
52-wk High
$56.75
52-wk Low
$18.25

Chart for

About

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along... (more)

Overall

Beta: -0.39
Market Cap(Mil.): $1,360.47
Shares Outstanding(Mil.): 38.32
Dividend: --
Yield (%): --

Financials

  AXGN.OQ Industry Sector
P/E (TTM): -- 47.56 32.45
EPS (TTM): -0.50 -- --
ROI: -19.39 8.31 12.63
ROE: -21.86 12.22 14.80

BRIEF-Axogen, Inc. Announces Appointment Of Karen Zaderej As Chairman Of The Board

* AXOGEN, INC. ANNOUNCES APPOINTMENT OF KAREN ZADEREJ AS CHAIRMAN OF THE BOARD

May 21 2018

BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman

* AXOGEN INC SAYS ON MAY 15, BOARD ELECTED CEO KAREN ZADEREJ TO SUCCEED JAMIE GROOMS AS CHAIRMAN OF BOARD - SEC FILING Source http://bit.ly/2Iqgb8O Further company coverage:

May 18 2018

BRIEF-Axogen Inc Announces Closing Of Public Offering Of Common Stock

* AXOGEN, INC. ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 14 2018

BRIEF-AxoGen Upsizes Public Offering To 3 Mln Shares At $41 Per Share

* AXOGEN, INC. ANNOUNCES UPSIZING AND PRICING OF PUBLIC OFFERING OF COMMON STOCK

May 09 2018

BRIEF-AxoGen Announces Proposed Public Offering Of Common Stock

* AXOGEN INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF 2 MILLION SHARES OF ITS COMMON STOCK

May 07 2018

BRIEF-AxoGen Reports Q1 Loss Per Share Of $0.16

* FY2018 REVENUE VIEW $84.9 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 30 2018

Competitors

Earnings vs. Estimates